PMID: 11931715Apr 5, 2002Paper

Pharmacogenetics of Lipid-lowering Therapies

Current Atherosclerosis Reports
J M Ordovas, Haiqing Shen

Abstract

Cardiovascular disease is associated with nonmodifiable risk factors such as age, gender, and genetic background, and with modifiable risk factors such as lipid concentrations. Lowering serum lipid levels has been demonstrated to slow the progression of, or even induce regression in, atherosclerosis. However, like any other drug treatment, the magnitude of plasma lipid responses to drug therapies varies considerably among individuals. Pharmacogenetics provides the experimental basis to understand the variability in response to drugs as a function of the individual genetic makeup. Information from small clinical trials reveals that several candidate genes may hold some promise in our quest to predict individual success to hypolipemic drug treatment. However, the current clinical relevance of this knowledge is quite limited due to the small effects observed for each of the genetic markers examined. Future progress in this area will be driven by studying gene-gene and gene-treatment interactions in much larger patient populations.

References

Jan 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P W ConnellyJ A Little
Nov 1, 1982·Atherosclerosis·W C BreckenridgeG Gardiner
Nov 1, 1995·Circulation Research·C M DolleryA M Henney
Oct 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J FerrièresS Lussier-Cacan
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Aug 28, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Y Somekawa, A Wakabayashi
Jan 23, 1999·The American Journal of Cardiology·P O Kwiterovich
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·A M HeikkinenS Saarikoski
May 17, 2000·Nutrition Reviews·J M Ordovas
Jun 24, 2000·Annals of the New York Academy of Sciences·A M HenneyA Hamsten
Sep 9, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M TomásJ Marrugat
Sep 26, 2000·Molecular Genetics and Metabolism·D E Comings, J P MacMurray
Dec 21, 2000·Current Atherosclerosis Reports·J M Ordovas, E J Schaefer
Feb 24, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·H ElghannamA J Marian
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H L McLeod, W E Evans
Apr 5, 2001·Current Atherosclerosis Reports·J M Ordovas
Nov 1, 2001·Nature Genetics
Nov 10, 2001·Annual Review of Genomics and Human Genetics·W E Evans, J A Johnson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Current Opinion in Lipidology
J M Ordovas, V Mooser
European Journal of Clinical Investigation
A-L García-OtínATOMIX Study Group. Atorvastatin in Mixed dyslipidemia
The Medical Clinics of North America
Ragavendra R Baliga, Jagat Narula
European Journal of Pharmacology
P Charron, M Komajda
© 2022 Meta ULC. All rights reserved